467 related articles for article (PubMed ID: 19122268)
21. [Therapeutic agents for disorders of bone and calcium metabolism--Parathyroid hormone in weekly subcutaneous injection].
Uzawa T
Clin Calcium; 2007 Jan; 17(1):56-62. PubMed ID: 17211094
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of osteoporosis with parathyroid hormone].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
[TBL] [Abstract][Full Text] [Related]
23. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
24. Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models.
Zambon A; Baio G; Mazzaglia G; Merlino L; Corrao G
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):260-9. PubMed ID: 18240162
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid hormone treatment for osteoporosis.
Cosman F
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):495-501. PubMed ID: 18971677
[TBL] [Abstract][Full Text] [Related]
26. [Parathyroid hormone for osteroporsis: why and who to treat?].
Ferrari S; Rizzoli R
Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
[TBL] [Abstract][Full Text] [Related]
27. Treatment of osteoporosis: all the questions we still cannot answer.
Laroche M
Am J Med; 2008 Sep; 121(9):744-7. PubMed ID: 18724959
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
[TBL] [Abstract][Full Text] [Related]
29. [Male osteoporosis: current treatments and future options].
Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
[TBL] [Abstract][Full Text] [Related]
30. Treatment of osteoporosis: combination therapies.
Simon JA; Mack CJ
Int J Fertil Womens Med; 2003; 48(3):127-31; discussion 137-8. PubMed ID: 12839144
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of osteoporosis in octogenarians].
Pepersack T
Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
[TBL] [Abstract][Full Text] [Related]
32. [Treatment with bisphosphonates: daily or once-weekly oral administration and intravenous injection].
Kitahama S; Ishii T; Wada S
Clin Calcium; 2005 Apr; 15(4):649-54. PubMed ID: 15802779
[TBL] [Abstract][Full Text] [Related]
33. Clinical and therapeutic aspects of osteoporosis.
Compston J
Eur J Radiol; 2009 Sep; 71(3):388-91. PubMed ID: 19660883
[TBL] [Abstract][Full Text] [Related]
34. [Genetic basis for skeletal disease. Osteogenesis imperfecta].
Tanaka H
Clin Calcium; 2010 Aug; 20(8):1245-52. PubMed ID: 20675936
[TBL] [Abstract][Full Text] [Related]
35. [Bisphosphonate therapy for osteoporosis and bone strength].
Kishimoto H
Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone update.
Hamann KL; Lane NE
Rheum Dis Clin North Am; 2006 Nov; 32(4):703-19. PubMed ID: 17288973
[TBL] [Abstract][Full Text] [Related]
37. [Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?].
Miki T; Saito S
Clin Calcium; 2006 Jan; 16(1):167-74. PubMed ID: 16397368
[TBL] [Abstract][Full Text] [Related]
38. Preferences of patients receiving bisphosphonates--how to influence the therapeutic adherence.
Payer J; Killinger Z; Sulková I; Celec P
Biomed Pharmacother; 2008 Feb; 62(2):122-4. PubMed ID: 17888616
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of osteoporotic fracture by pharmaceutical interventions].
Nakamura T
Clin Calcium; 2006 Dec; 16(12):1961-67. PubMed ID: 17142925
[TBL] [Abstract][Full Text] [Related]
40. Patient treatment preferences for osteoporosis.
Fraenkel L; Gulanski B; Wittink D
Arthritis Rheum; 2006 Oct; 55(5):729-35. PubMed ID: 17013870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
